Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 20/20 | 0.75 |
| ▸ | CDK6 | Q00534 | 19/20 | 0.75 |
| ▸ | CSF1R | P07333 | 9/20 | 0.74 |
| ▸ | CCNA2 | P20248 | 6/20 | 0.74 |
| ▸ | CDK2 | P24941 | 6/20 | 0.74 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.74 |
| ▸ | CCNK | O75909 | 3/20 | 0.74 |
| ▸ | CDK9 | P50750 | 3/20 | 0.74 |
| ▸ | CDK7 | P50613 | 1/20 | 0.71 |
| ▸ | CCNH | P51946 | 1/20 | 0.71 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.71 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21267580 | 0.88 | CDK4 (0.78) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL21245676 | 0.86 | CDK4 (0.80) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL21245849 | 0.86 | CDK6 (1.00) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL21267212 | 0.85 | CDK4 (0.71) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL21267572 | 0.85 | CDK6 (0.76) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL21245568 | 0.85 | CDK4 (1.00) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL21267189 | 0.85 | CDK4 (0.72) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL21267186 | 0.85 | CDK6 (0.80) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL28540158 | 0.84 | CDK4 (0.71) | CDK4CDK6CSF1RCCNA2CDK2 | |
| SCHEMBL21267886 | 0.84 | CDK4 (0.71) | CDK4CDK6CSF1RCCNA2CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112334451-A | Heterocyclic compounds as kinase inhibitors | 诺维逊生物股份有限公司 | 2021-02-05 | — | — | CN | disclosed |